![]() |
|
|
PC Liu and F Matsumura
Department of Environmental Toxicology, University of California, Davis 95616.
One prominent symptom of acute toxicity from 2,3,7,8-tetrachlorodibenzo- p- dioxin (TCDD) is a loss of adipose tissue and body weight, a phenomenon known as the wasting syndrome. In the current study, we examined the effect of TCDD on glucose transport in mice. A single intraperitoneal dose of TCDD (116 micrograms/kg) resulted in a time- dependent decrease in transport activity in adipose tissue and brains of C57BL/6 mice. Reduction of transport occurred within 24 hr in both tissues. In adipose tissue a slight recovery was observed by 30 days, but in the brains of treated animals glucose transport was significantly decreased even at the latest time. A comparison of dose- response relationships for several tissues between C57BL/6 (TCDD- responsive) and DBA/2J (TCDD-nonresponsive) mice showed parallel curves, with the C57BL/6 animals showing a 10-20-fold greater sensitivity. The estimated ED50 values for reduction of transport in adipose tissue were 50 micrograms/kg and 800 micrograms/kg for the C57BL/6 and DBA/2J strains, respectively. Treatment of isolated adipose tissue in culture with TCDD and two biphenyl congeners produced a decrease in transport activity that matched the rank order of aryl hydrocarbon receptor affinity for the compounds. Immunoblotting for the adipose-type (type 4) glucose transporter (GLUT) showed a 40% decrease in the membrane fraction of adipose tissue from C57BL/6 mice treated with 116 micrograms/kg TCDD for 40 hr. A similar decrease in the brain- type GLUT1 was observed in the plasma membrane fraction of brain tissues isolated from the same animals. Analysis of RNA for the corresponding GLUT4 and GLUT1 genes showed a dramatic decrease in GLUT4 mRNA as early as 24 hr after treatment. In contrast, the level of GLUT1 mRNA increased slightly in the brains of treated mice. We conclude that regulation by TCDD of glucose transport activity in mice is an aryl, hydrocarbon receptor-dependent process and that the adipose-type GLUT4 appears to be regulated at the mRNA level, whereas the brain-type GLUT1 is affected mainly at the protein level.
This article has been cited by other articles:
![]() |
S. Tonack, K. Kind, J. G. Thompson, A. M. Wobus, B. Fischer, and A. N. Santos Dioxin Affects Glucose Transport via the Arylhydrocarbon Receptor Signal Cascade in Pluripotent Embryonic Carcinoma Cells Endocrinology, December 1, 2007; 148(12): 5902 - 5912. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liu and C. Jefcoate 2,3,7,8-Tetrachlorodibenzo-p-dioxin and Epidermal Growth Factor Cooperatively Suppress Peroxisome Proliferator-Activated Receptor-{gamma}1 Stimulation and Restore Focal Adhesion Complexes during Adipogenesis: Selective Contributions of Src, Rho, and Erk Distinguish These Overlapping Processes in C3H10T1/2 Cells Mol. Pharmacol., December 1, 2006; 70(6): 1902 - 1915. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-H. Lee, I.-K. Lee, K. Song, M. Steffes, W. Toscano, B. A. Baker, and D. R. Jacobs Jr A Strong Dose-Response Relation Between Serum Concentrations of Persistent Organic Pollutants and Diabetes: Results from the National Health and Examination Survey 1999-2002 Diabetes Care, July 1, 2006; 29(7): 1638 - 1644. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cranmer, S. Louie, R. H. Kennedy, P. A. Kern, and V. A. Fonseca Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Is Associated with Hyperinsulinemia and Insulin Resistance Toxicol. Sci., August 1, 2000; 56(2): 431 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Moreno-Aliaga and F. Matsumura Endrin Inhibits Adipocyte Differentiation by Selectively Altering Expression Pattern of CCAAT/Enhancer Binding Protein-alpha in 3T3-L1 Cells Mol. Pharmacol., July 1, 1999; 56(1): 91 - 101. [Abstract] [Full Text] |
||||